Regeneron Pharmaceuticals Inc. closed 54.89% short of its 52-week high of $1,211.20, which the company reached on August 27th ...

Guggenheim analyst Yatin Suneja lowered the firm’s price target on Regeneron (REGN) to $940 from $950 and keeps a Buy rating on the shares. The ...

As Fierce Pharma points out, patent expirations are a routine occurrence in the pharmaceutical world, but 2025 stands out for ...

Bronte Capital’s latest quarterly performance has delivered some reprieve for investors after Hempton put his struggling ...

A proud Limerick woman is taking on a mean feat this summer to raise funds for an animal charity close to her heart.

DeKalb Central schools students attended the State Science Fair competition on Saturday at the Indiana University campus in Indianapolis.

ADAR1 Capital Management LLC dramatically boosted its holdings in Regeneron Pharmaceuticals by 56.3% during Q4, grabbing 1,361 shares worth nearly $969,000. Several other institutional investors also ...